9INP
Human Pin1 (Peptidyl-prolyl cis-trans isomerase) catalytic domain in complex with a covalent inhibitor
This is a non-PDB format compatible entry.
Summary for 9INP
Entry DOI | 10.2210/pdb9inp/pdb |
Descriptor | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1, ~{N}-[(3~{R})-1,1-bis(oxidanylidene)thiolan-3-yl]-2-chloranyl-~{N}-(2,2-dimethylpropyl)-5-nitro-pyrimidin-4-amine, CITRIC ACID, ... (4 entities in total) |
Functional Keywords | peptidyl-prolyl cis-trans isomerase, pin1, covalent inhibitor, isomerase |
Biological source | Homo sapiens (human) |
Total number of polymer chains | 2 |
Total formula weight | 27723.57 |
Authors | |
Primary citation | Tian, M.,Wang, X.,Tang, G.,Cui, G.,Zhou, J.,Jin, J.,Xu, B. Discovery of Novel Pyrimidine Derivatives as Human Pin1 Covalent Inhibitors. Acs Med.Chem.Lett., 16:101-108, 2025 Cited by PubMed Abstract: Pin1 (peptidyl-prolyl cis-trans isomerase NIMA-interacting 1) is a unique peptidyl-prolyl isomerase (PPIase), and inactivation of Pin1 with a covalent inhibitor is a potential strategy for developing anticancer agents. Herein, a series of sulfolane amino-substituted 2-chloro-5-nitropyrimidine derivatives were disclosed as structurally distinct covalent inhibitors toward Pin1, which were validated for their covalent binding to Cys113 of Pin1 by X-ray cocrystal structures of compounds (IC = 11.55 μM) and (IC = 3.15 μM). This work provided a new approach for covalent inhibition of Pin1 by taking advantage of the 2-chloro-5-nitropyrimidine as the electrophilic warhead, which might benefit the discovery of potent and drug-like Pin1 inhibitors. PubMed: 39811131DOI: 10.1021/acsmedchemlett.4c00477 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.57 Å) |
Structure validation
Download full validation report
